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Abstract
Background—The concern that adolescent girls who receive human papillomavirus (HPV) 
vaccine may be more likely to have sex (ie, sexual disinhibition) has been commonplace in media 
coverage, but this belief is not held by many parents of adolescent girls. Because no studies have 
addressed this topic for adolescent boys, we examined parents’ and their adolescent sons’ beliefs 
in sexual disinhibition occurring after boys receive HPV vaccine.
Methods—A national sample of parents of adolescent boys (n = 547) and their sons (aged 15–17 
years; n = 176) completed online surveys in fall 2010. We used multi-item scales to measure 
parents’ and sons’ beliefs in sexual disinhibition after HPV vaccination. We used multivariate 
linear regression to identify correlates of beliefs in sexual disinhibition.
Results—Less than a quarter of parents or sons agreed with statements suggesting that HPV 
vaccination leads to sexual disinhibition among adolescent boys (range, 20%–24%). Parents who 
had more liberal political affiliations (β = −0.11), had a daughter who had received HPV vaccine 
(β = −0.12), or had no daughter (β = −0.10) reported weaker beliefs in sexual disinhibition. Parents 
who reported higher anticipated regret if their sons got HPV vaccine and fainted (β = 0.18) 
indicated stronger beliefs in sexual disinhibition. Sons who perceived higher peer acceptance of 
HPV vaccination (β = 0.44) or were Hispanic (β = 0.21) had stronger beliefs in sexual 
disinhibition.
Conclusions—Most parents and sons did not believe that HPV vaccination leads to sexual 
disinhibition among boys. Understanding the characteristics of parents and sons who hold these 
beliefs may help inform efforts to increase HPV vaccine uptake among boys.
Human papillomavirus (HPV) is the most common sexually transmitted infection (STI) in 
the United States, with an estimated 6.2 million new infections each year.1 Human 
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papillomavirus vaccine, which was first recommended for females in the United States,2 is 
now also recommended for males to prevent genital warts and anal cancer. As of October 
2011, national guidelines recommend that all adolescent boys aged 11 to 12 years receive 
the 3-dose HPV vaccine regimen, with catch-up vaccination for boys and men aged 13 to 21 
(and through age 26 years for men who have sex with men).3 However, vaccine coverage 
remains extremely low among adolescent boys, with recent data suggesting that 14% or 
fewer adolescent boys have received any doses of the vaccine.4–6 Increasing HPV coverage 
among adolescent boys is important because vaccination may play an important role in 
curbing rising rates of genital warts and HPV-related cancers among men.7
One much discussed potential barrier to increasing coverage is the belief that HPV 
vaccination may cause adolescents to engage in sexual behavior (ie, sexual disinhibition). 
This folk belief may arise because of the link between the vaccine and HPV, an STI. 
Another source may be media stories about the vaccine.8,9 Despite the popularity of this 
topic in public discourse, past studies have shown that only 6% to 31% of parents with 
adolescent daughters believe that sexual disinhibition will occur among vaccinated 
girls.10–15 Furthermore, a British study of adolescent girls found that around 30% agreed 
that HPV vaccination would make adolescent girls more likely to have sex.12
The veracity and impact of such beliefs have been the topic of considerable research. 
Multiple well-designed studies have found that HPV vaccination is not associated with 
markers of sexual behavior among adolescent girls, including rates of STIs and 
pregnancy.16,17 Although concerns about this issue seem to correlate with lower interest in 
vaccinating adolescent girls against HPV in cross-sectional studies,18,19 our own 
longitudinal work showed that such beliefs are the result of not vaccinating, not a cause of 
it.20 Data from this same study indicated that less than 1% of parents showed concerns about 
sexual disinhibition as their main reason for not having vaccinated their adolescent 
daughters.21
No studies, to our knowledge, have examined parents’ and adolescents’ beliefs in sexual 
disinhibition among boys after HPV vaccination. The present study uses data from a 
national sample of parents and their adolescent sons to determine the prevalence of this 
belief and identify correlates of having this belief. Based on our previous research among 
parents of adolescent girls,14 we hypothesized that parents who were younger and more 
liberal in their political views would have weaker beliefs in sexual disinhibition occurring 
among boys who receive HPV vaccine. We also hypothesized that sons with higher 




The HPV Immunization in Sons study surveyed parents and their 11- to 17-year-old sons to 
examine their attitudes and beliefs in HPV vaccination for boys.22 We recruited parents 
from a national online panel maintained by a survey company.23 The online panel is 
constructed through list-assisted, random-digit dialing supplemented by address-based 
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sampling. The resulting panel represents a probability-based sample of US households. 
Panel members receive a laptop and free Internet access in exchange for completing multiple 
online surveys each month. Panel members in households with existing computer and 
Internet access accumulate points for completing surveys that can later be redeemed for 
small cash payments.
We asked participating parents to also allow their sons to participate in our study. Any 
parent with multiple sons in the eligible age range answered questions about the son with the 
most recent birthday who then became eligible for participation in the study. Parents 
provided consent to participate for both themselves and their sons before the start of parent 
surveys, and sons provided assent before the start of their surveys. Sons received 5000 
points (equivalent to approximately US $5) for completing the survey. The survey company 
e-mailed 1195 adults, who likely had age-eligible male children, to invite them to complete 
baseline surveys. Among the 752 parents who responded, 73% (n = 547) were eligible and 
completed the parent survey, and 56% (n = 421) had sons who completed the son survey. 
We report data on all parents who completed surveys and 176 sons aged 15 to 17 years 
because sexual disinhibition items were not asked of younger sons.
Measures
Surveys for the HPV Immunization in Sons study are available online at http://
www.unc.edu/~ntbrewer/hpv.htm. We developed survey items based on our previous HPV 
vaccine survey research.24–26 We cognitively tested survey items (with 6 parents and 6 
sons), refined the items, and then pretested the surveys (with 31 parents and 23 adolescent 
sons) before data collection.
Outcome Variables—Surveys assessed parents’ (3 items, α = 0.76) and sons’ (2 items, α 
= 0.83) beliefs in sexual disinhibition occurring after HPV vaccination. Survey items for 
parents/sons read the following: (1) “If [son’s name/I] got the HPV vaccine, [his] girlfriends 
would think it was safe to take more risks,” and (2) “If [son’s name/I] got the HPV vaccine, 
[he/I] would think it was safe to take more risks.” We modified items used in past HPV 
vaccine research in creating these 2 items.27 The survey asked parents a third sexual 
disinhibition item, “If a teenage boy gets the HPV vaccine, he may be more likely to have 
sex.” The 5-point scale used for disinhibition items read “strongly disagree,” “disagree,” 
“not sure,” “agree,” and “strongly agree” (coded 1–5).
Correlates—We have previously described the survey items examined as potential 
correlates.22 Surveys assessed parents’ worry about their sons getting HPV-related disease, 
perceived likelihood of their sons getting HPV-related disease, and perceived effectiveness 
of HPV vaccine against genital warts (all items had a possible range = 1–4). We asked 
parents if they had heard of HPV before today, if they thought their sons’ insurance covered 
HPV vaccine, and if their sons’ doctors had ever recommended HPV vaccine for their sons. 
Surveys assessed parents’ comfort in talking with their sons about new vaccines (2 items, α 
= 0.68, possible range = 1–5) and the amount they had discussed HPV vaccine with their 
sons (possible range = 1–4). Surveys assessed parents’ anticipated regret if their sons fainted 
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after receiving HPV vaccine as well as anticipated regret if their sons did not get vaccinated 
and later developed an HPV infection (both items had a possible range = 1–4).
We used several survey items from the Carolina HPV Immunization Attitudes and Beliefs 
Scale.28 Items from this scale measured parents’ perceived barriers to getting their sons 
HPV vaccine (2 items, α = 0.62, possible range = 1–3) and uncertainty about HPV vaccine 
(3 items, α = 0.55, possible range = 1–5). We determined if sons had received any doses of 
HPV vaccine and if sons had any female siblings aged 9 to 26 years who had received any 
doses of HPV vaccine.
The son survey included 5 items that we used to classify sons as follows: (a) unaware of 
HPV (never heard of HPV before the survey), (b) aware with low HPV knowledge 
(answered 2 or fewer knowledge items correctly), or (c) aware with high knowledge 
(answered 3 or more knowledge items correctly). We measured sons’ perceived knowledge 
about HPV vaccine (possible range = 1–4), potential embarrassment if they got vaccinated 
(2 items, α = 0.90, possible range = 1–5), and peer acceptance of HPV vaccine (4 items, α = 
0.69, possible range = 1–5). We used items and response scales that corresponded to those 
on the parent survey to measure sons’ perceived likelihood of HPV-related disease (possible 
range = 1–4), comfort in talking with their parents about new vaccines (2 items, α = 0.71, 
possible range = 1–5), the amount they had talked with their parents about HPV vaccine 
(possible range = 1–4), anticipated regret if they received HPV vaccine and fainted (possible 
range = 1–4), and anticipated regret if they did not receive HPV vaccine and later developed 
an HPV infection (possible range = 1–4).
We collected information on several demographic variables (Table 1). We defined “rural” as 
living outside a metropolitan statistical area and “urban” as living inside of a metropolitan 
statistical area. We asked parents if they considered themselves to be born-again or 
evangelical Christians. Surveys measured parents’ political affiliation (responses ranging 
from “very conservative” to “very liberal”; possible range = 1–5) and importance of religion 
(responses ranging from “not at all important” to “extremely important”; possible range = 1–
5).
Data Analysis
We used linear regression to identify bivariate correlates of parents’ and sons’ beliefs in 
sexual disinhibition occurring after HPV vaccination. We entered statistically significant 
correlates (P < 0.05) into separate multivariate linear regressions for parents and sons. We 
report standardized regression coefficients (β) from these analyses. We calculated Pearson 
correlation coefficient to determine correlations between parents’ and sons’ beliefs in sexual 
disinhibition and used paired t tests to make comparisons. Analyses used SPSS version 17.0 
(SPSS Inc, Chicago IL), with all statistical tests being 2 tailed and having a critical α of 
0.05.
Mayer et al. Page 4
























Parents were mostly female (54%), younger than 45 years (61%), non-Hispanic white 
(67%), and were married or living with a partner (82%) (Table 1). Approximately half of 
parents had completed at least some college (56%) and reported a household income of less 
than US$60,000 (51%). Parents were from all 4 geographic regions of the United States, 
with most residing in urban areas (83%). Most parents had heard of HPV before the survey 
(79%). Sons included in these analyses were aged 15 to 17 years and mostly non-Hispanic 
white (66%). More than half of sons had not heard of HPV before the survey (60%), 15% 
had heard of HPV and had low knowledge about it, and 25% had heard of HPV and had 
high knowledge.
Parents’ Sexual Disinhibition Beliefs
Parents reported modest beliefs that HPV vaccine would cause sexual disinhibition among 
boys who receive it (mean [SD], 2.76 [0.83]). With respect to individual scale items, 
approximately 20% of parents strongly agreed or agreed that teenage boys who get HPV 
vaccine maybe more likely to have sex (Fig. 1). Similar percentages of parents strongly 
agreed or agreed that if their sons got HPV vaccine, his girlfriends would think it was safe to 
take more risks (21%) or the sons would think it was safe to take more risks (23%).
In a multivariate analyses, parents who reported higher anticipated regret if their sons got 
HPV vaccine and fainted (β = 0.18) indicated stronger beliefs in sexual disinhibition (Table 
2). Parents who reported more liberal political affiliations (β = −0.11), had a daughter who 
had received HPV vaccine (β = −0.12), or did not have a daughter (β = −0.10) reported 
weaker beliefs in sexual disinhibition. Variables that were statistically significant in 
bivariate but not multivariate analyses were parent sex, perceived uncertainty about HPV 
vaccine, awareness of HPV, perceived barriers to getting sons HPV vaccine, if parents 
thought their sons’ insurance covers HPV vaccine, and if sons’ doctors had recommended 
HPV vaccination.
Sons’ Sexual Disinhibition Beliefs
As with the parents, many sons did not believe that receiving HPV vaccine would lead 
adolescent boys to be more sexually active (mean [SD], 2.79 [0.94]). Approximately 22% of 
sons strongly agreed or agreed that if they received HPV vaccine, their girlfriends would 
think it was safe to take more risks (Fig. 1). Approximately 24% of sons strongly agreed or 
agreed that if they received HPV vaccine, they would think it was safe to take more risks.
In multivariate analyses, Hispanic ethnicity (β = 0.21) and perceived peer acceptance of 
HPV vaccine (β = 0.44) remained associated with beliefs in sexual disinhibition after HPV 
vaccination (Table 3). In bivariate analyses, sons’ perceived likelihood of getting HPV-
related disease was also associated with beliefs in sexual disinhibition.
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Correlation Between Parents’ and Sons’ Beliefs
Among the 176 parent-son dyads who were asked sexual disinhibition questions, parent and 
son responses were correlated. We found a positive correlation for both belief that 
girlfriends would think that it was safe to take more risks after HPV vaccination among sons 
(r = 0.26, P < 0.001) and belief that sons would think it was safe to take more risks after 
HPV vaccination (r = 0.44, P < 0.001). Among these dyads, sons and parents reported 
similar beliefs that HPV vaccination would lead sons to think it would be safe to take more 
risks (means, 2.70 vs. 2.64) and would lead sons’ girlfriends to think it would be safe to take 
more risks (means, 2.88 vs. 2.76; both P > 0.05).
DISCUSSION
Although studies have examined beliefs in sexual disinhibition among adolescent girls and 
their parents,10–15 it is important to examine such beliefs about vaccinating boys against 
HPV. A minority of parents agreed that HPV vaccination could lead to sexual disinhibition 
among adolescent boys, with items ranging from 20% to 23% agreement. This proportion is 
within the range of parental agreement with sexual disinhibition resulting from HPV 
vaccination found among parents of adolescent girls, which ranged from 6% to 31% in past 
studies.10–15 Among adolescent boys, agreement with sexual disinhibition items ranged 
from 22% to 24%. This proportion is somewhat comparable with the 30% of adolescent girls 
endorsing this belief found in one British study.12 These findings add to the body of 
evidence that beliefs in HPV-induced sexual disinhibition are not held by most parents and 
adolescents.
Several variables among parents and sons were correlated with stronger beliefs about sexual 
disinhibition occurring among boys who receive HPV vaccine. Although a minority of 
parents and adolescent sons held this belief, these correlates identify subgroups that may 
hold stronger beliefs about sexual disinhibition. Such information may be useful to consider 
in designing messages and strategies to help increase HPV vaccination among boys. Our 
results support our expectation that parents with more liberal political beliefs would have 
weaker beliefs about sexual disinhibition. This finding is consistent with a past study that 
found that conservative political beliefs were associated with greater concern about sexual 
disinhibition occurring among adolescent girls who receive HPV vaccine.14 Because parent 
age was not associated with beliefs in sexual disinhibition, our hypothesis that older parents 
would express stronger beliefs in sexual disinhibition was not supported. Past studies have 
found a null or positive association between parent age and endorsement of sexual 
disinhibition beliefs.11,12,14
Parents who had daughters who had received HPV vaccine were less likely to endorse HPV-
induced sexual disinhibition beliefs. This is similar to a previous study that found that 
parents with daughters who had received HPV vaccine were less likely to express beliefs 
sexual disinhibition.14 It is possible that the parents with vaccinated daughters in our study 
did not observe increased sexual activity in their daughters after HPV vaccination and are 
therefore less worried about sexual disinhibition occurring among their sons. Parents in our 
study who did not have daughters were also less likely to agree with HPV-induced sexual 
disinhibition compared with parents with unvaccinated daughters. This may be caused by 
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the fact that parents without daughters are not as aware of concerns about sexual 
disinhibition. Lastly, parents who anticipated greater regret if their sons were vaccinated and 
fainted had stronger beliefs about sexual disinhibition after HPV vaccination. These parents 
who anticipate higher regret if fainting occurred after vaccination may simply be more 
worried about other potential negative outcomes, including sexual disinhibition. Our study 
also provides valuable insight into correlates of beliefs about sexual disinhibition among 
sons. Hispanic sons were more likely to agree that HPV vaccine may lead to sexual 
disinhibition.
It may be important to address this belief among Hispanic males because they are more 
likely to be infected with multiple HPV types as compared with non-Hispanic whites.29 
However, early data suggest that Hispanic boys have higher HPV vaccine initiation rates, so 
sexual disinhibition beliefs among Hispanic boys may not actually reduce their uptake of 
HPV vaccine.6 Perceived peer acceptance of HPV vaccine was positively associated with 
beliefs in HPV-induced sexual disinhibition, suggesting that boys might not see sexual 
disinhibition as an especially bad thing.
The present study has many strengths including a national sample and interviews with both 
parents and their adolescent sons. We cognitively tested our surveys before data collection, 
which may have contributed to the sexual disinhibition scales having good internal 
consistency. Study limitations include the inability to compare vaccinated and unvaccinated 
sons on beliefs about sexual disinhibition because so few sons had received any doses of 
HPV vaccine. Most participants were non-Hispanic white and of higher socioeconomic 
status, although the online panel our sample was drawn from is demographically similar to 
the US population.30 Panel members received incentives to regularly complete online 
surveys, which may have affected responses to our survey items. In addition, our surveys 
were conducted in fall 2010, about a year before the HPV vaccine was recommended for 
routine use among adolescent boys.3 It is possible that parents’ and sons’ beliefs in sexual 
disinhibition may have changed because HPV vaccine has been available for a longer period 
for adolescent boys.
Most parents and adolescent sons did not believe that HPV vaccination leads to sexual 
disinhibition among adolescent boys. Certain subgroups of parents (eg, those who have 
conservative political beliefs) and sons (eg, Hispanics) may hold stronger beliefs about 
sexual disinhibition. This information may be helpful to practitioners developing messages 
and strategies to increase HPV vaccination.
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Parent and son responses to sexual disinhibition items.
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TABLE 1




    Female 294 (54)
    Male 253 (46)
  Age, y
    <45 332 (61)
    ≥45 215 (39)
  Race/Ethnicity
    White, non-Hispanic 366 (67)
    African American, non-Hispanic 69 (13)
    Hispanic 83 (15)
    Other 29 (5)
  Marital status
    Divorced, widowed, separated, never married 101 (19)
    Married or living with partner 446 (82)
  Education
    High school degree or less 242 (44)
    Some college or more 305 (56)
  Born-again Christian
    No 363 (66)
    Yes 184 (34)
  Importance of religion, mean (SD)* 3.60 (1.35)
  Political Affiliation, mean (SD)† 2.62 (0.98)
  Heard of HPV before survey
    No 116 (21)
    Yes 431 (79)
Son characteristics‡
  Age, y
    15 41 (23)
    16 62 (35)
    17 73 (42)
  Race/Ethnicity
    White, non-Hispanic 116 (66)
    African American, non-Hispanic 23 (13)
    Hispanic 28 (16)
    Other 9 (5)
  Seen regular health care provider in last year
    No 49 (28)
    Yes 127 (72)
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n (%)
  Knowledge about HPV
    Never heard of HPV before survey 105 (60)
    Heard of HPV, low knowledge 27 (15)
    Heard of HPV, high knowledge 44 (25)
Household characteristics
  Household income
    <US $60,000 279 (51)
    ≥US $60,000 268 (49)
  Urbanicity
    Rural 94 (17)
    Urban 453 (83)
  Region of residence
    Northeast 114 (21)
    Midwest 134 (25)
    South 188 (34)
    West 111 (20)
*
Five-point response scale ranging from “not at all important” to “very important” (coded 1–5).
†
Five-point response scale ranging from “very conservative” to “very liberal” (coded 1–5).
‡
Data collected during parent survey, but we report data only for those sons who completed their own surveys and were aged 15 to 17 years.
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TABLE 2
Parents’ Beliefs in Sexual Disinhibition After HPV Vaccination (n = 547)
n (%)








    Female 294 (54) 2.68 (0.82) Ref Ref
    Male 253 (46) 2.84 (0.83) 0.10* 0.04
  Age, y
    <45 332 (61) 2.75 (0.83) Ref —
    ≥45 215 (39) 2.78 (0.82) 0.02 —
  Race/Ethnicity
    White, non-Hispanic 366 (67) 2.71 (0.82) Ref —
    African American, non-Hispanic 69 (13) 2.79 (0.81) 0.03 —
    Hispanic 83 (15) 2.88 (0.87) 0.07 —
    Other 29 (5) 2.89 (0.87) 0.05 —
  Marital status
    Divorced, widowed, separated, never married 101 (19) 2.73 (0.84) Ref —
    Married or living with partner 446 (82) 2.76 (0.83) 0.01 —
  Education
    High school degree or less 242 (44) 2.82 (0.81) Ref —
    Some college or more 305 (56) 2.71 (0.84) −0.07 —
  Born-again Christian
    No 363 (66) 2.75 (0.82) Ref —
    Yes 184 (34) 2.77 (0.84) 0.01 —
  Importance of religion†,‡ 3.60 (1.35) N/A 0.08 —
  Political affiliation†,§ 2.62 (0.98) N/A −0.13¶ −0.11¶
Son characteristics
  Age, y
    11–12 172 (31) 2.80 (0.81) Ref —
    13–15 198 (36) 2.78 (0.86) −0.01 —
    16–17 177 (32) 2.69 (0.81) −0.07 —
  Seen regular health care provider in last year
    No 120 (22) 2.74 (0.75) Ref —
    Yes 427 (78) 2.76 (0.85) 0.01 —
  Received any doses of HPV vaccine
    No 535 (98) 2.76 (0.83) Ref —
    Yes 12 (2) 2.61 (0.93) −0.03 —
Household characteristics
  Household income
    <US $60,000 279 (51) 2.78 (0.82) Ref —
    ≥US $60,000 268 (49) 2.73 (0.84) −0.03 —
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    Rural 94 (17) 2.77 (0.84) Ref —
    Urban 453 (83) 2.75 (0.83) −0.01 —
  Region of residence
    Midwest 134 (24) 2.77 (0.78) Ref —
    Northeast 114 (21) 2.76 (0.87) −0.01 —
    South 188 (34) 2.75 (0.89) −0.01 —
    West 111 (20) 2.74 (0.74) −0.02 —
HPV and HPV vaccine
  Heard of HPV before survey
    No 166 (21) 3.00 (0.83) Ref Ref
    Yes 431 (79) 2.69 (0.82) −0.15¶ −0.07
  Worry about son getting HPV-related disease†,‖ 1.44 (0.75) N/A −0.06 —
  Perceived likelihood of son getting HPV-related disease†,** 2.18 (0.63) N/A −0.02 —
  Has a daughter who has received HPV vaccine
    No 200 (37) 2.90 (0.91) Ref Ref
    Yes 77 (14) 2.52 (0.77) −0.16¶ −0.12¶
    Does not have a daughter 270 (49) 2.71 (0.77) −0.11* −0.10*
  Comfort talking with son about new vaccines†,†† 4.36 (0.79) N/A −0.07 —
  Amount talked with son about HPV vaccine†,‖ 1.20 (0.53) N/A −0.06 —
  Thinks son’s insurance covers HPV vaccine
    No 57 (10) 2.88 (0.80) Ref Ref
    Yes 120 (22) 2.61 (0.83) −0.13* −0.03
    Don’t know 370 (68) 2.79 (0.83) −0.05 0.02
  Son’s doctor said son should get HPV vaccine
    No 523 (96) 2.77 (0.82) Ref Ref
    Yes 24 (4) 2.43 (0.88) −0.09* −0.06
    Perceived effectiveness of HPV vaccine†,‖ 2.40 (0.94) N/A −0.04 —
    Perceived uncertainty of HPV vaccine†,‡‡ 3.57 (0.67) N/A 0.10* 0.04
    Perceived barriers to getting son HPV vaccine†,§§ 1.35 (0.47) N/A 0.09* 0.04
    Anticipated regret if son got HPV vaccine and fainted†,‖ 2.72 (1.07) N/A 0.21¶ 0.18¶
    Anticipated regret if son didn’t get HPV vaccine and later got HPV 
infection†,‖
3.16 (0.95) N/A −0.07 —
Sexual disinhibition was measured using 3 items (α = 0.76) that each had a 5-point response scale ranging from “strongly disagree” to “strongly 




Continuous variable with overall mean (SD) reported.
‡
Five-point response scale ranging from “not at all important” to “very important” (coded 1–5).
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§




Four-point response scale ranging from “not at all” to “a lot” (coded 1–4).
**
Four-point response scale ranging from “no chance” to “high chance” (coded 1–4).
††
Two-item scale; each item had a 5-point response scale ranging from “very uncomfortable” to “very comfortable” (coded 1–5).
‡‡
Three-item scale; each item had a 5-point response scale ranging from “strongly disagree” to “strongly agree” (coded 1–5).
§§
Two-item scale; each item had a 3-point response scale ranging from “not hard at all” to “very hard” (coded 1–3).
Ref indicates referent group; N/A, not applicable due to variable being continuous.
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TABLE 3
Sons’ Beliefs in Sexual Disinhibition After HPV Vaccination (n = 176)
n (%)








  Age, y*
    15 41 (23) 2.89 (0.94) −0.01 —
    16 62 (35) 2.92 (0.86) Ref —
    17 73 (41) 2.62 (0.99) −0.16 —
  Race/Ethnicity*
    White, non-Hispanic 116 (66) 2.79 (0.92) 0.14 0.13
    African American, non-Hispanic 23 (13) 2.52 (0.91) Ref Ref
    Hispanic 28 (16) 3.09 (1.03) 0.22† 0.21†
    Other 9 (5) 2.56 (0.85) 0.01 0.01
  Seen regular health care provider in last year*
    No 49 (28) 2.83 (0.92) Ref —
    Yes 127 (72) 2.78 (0.95) −0.02 —
  Self-rated health‡,§ 3.91 (0.91) N/A −0.10 —
  Received any doses of HPV vaccine*
    No 171 (97) 2.79 (0.94) Ref —
    Yes 5 (3) 2.70 (1.10) −0.02 —
Household characteristics
  Urbanicity
    Rural 31 (18) 2.98 (0.94) Ref —
    Urban 145 (82) 2.75 (0.94) −0.10 —
  Region of residence
    South 54 (31) 2.61 (1.01) Ref —
    Northeast 39 (22) 2.82 (1.10) 0.09 —
    Midwest 50 (28) 2.89 (0.70) 0.13 —
    West 33 (19) 2.89 (0.95) 0.12 —
HPV and HPV vaccine
  Knowledge about HPV
    Never heard of HPV before survey 105 (60) 2.81 (0.87) Ref —
    Heard of HPV, low knowledge 27 (15) 2.78 (1.03) −0.01 —
    Heard of HPV, high knowledge 44 (25) 2.74 (1.06) −0.04 —
  Perceived likelihood of getting HPV-related disease‡,¶ 2.09 (0.65) N/A 0.17† 0.11
  Has a sister who has received HPV vaccine*
    No 65 (37) 2.73 (1.04) Ref —
    Yes 31 (18) 2.89 (0.67) 0.06 —
    Does not have a sister 80 (45) 2.80 (0.95) 0.04 —
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  Comfort talking with parents about new vaccines‡,‖ 3.66 (1.11) N/A −0.05 —
  Amount talked with parents about HPV vaccine‡,** 1.16 (0.46) N/A −0.04 —
  Perceived knowledge about HPV vaccine‡,†† 1.39 (0.66) N/A −0.11 —
  Perceived peer acceptance of HPV vaccine‡,‡‡ 3.06 (0.59) N/A 0.46§§ 0.44§§
  Potential embarrassment of getting HPV vaccine‡,¶¶ 2.84 (1.02) N/A 0.10 —
  Anticipated regret if got HPV vaccine and fainted‡,** 2.59 (1.10) N/A −0.11 —
  Anticipated regret if didn’t get HPV vaccine and later got HPV 
infection‡,**
3.16 (0.94) N/A 0.09 —
Sexual disinhibition was measured using 2 items (α = 0.83) that each had a 5-point response scale ranging from “strongly disagree” to “strongly 
agree” (coded 1–5). β represents standardized regression coefficients. Multivariate model did not include variables with dashes (—).
*




Continuous variable with overall mean (SD) reported.
§
Five-point response scale ranging from “poor” to “excellent” (coded 1–5).
¶
Four-point response scale ranging from “no chance” to “high chance” (coded 1–4).
‖
Two-item scale; each item had a 5-point response scale ranging from “very uncomfortable” to “very comfortable” (coded 1–5).
**
Four-point response scale ranging from “not at all” to “a lot” (coded 1–4).
††
Four-point response scale ranging from “nothing at all” to “a lot” (coded 1–4).
‡‡




Two-item scale; each item had a 5-point response scale ranging from “strongly disagree” to “strongly agree” (coded 1–5).
Ref indicates referent group; N/A, not applicable due to variable being continuous.
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